Boston, MANCT06400004Now EnrollingIRB Ready

I cannot determine a primary medical condition from the provided information. The data only shows drug names (Lumason/Sulfur Hexafluoride Lipid Type A Microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. Clinical Trial in Boston, MA

Access cutting-edge i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Bracco Diagnostics, Inc

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. treatment provided free

Apply for This Boston Location

Check if you qualify for this i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This I cannot determine a primary medical condition from the provided information. The data only shows drug names (Lumason/Sulfur Hexafluoride Lipid Type A Microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. Study in Boston

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).

Sponsor: Bracco Diagnostics, Inc

Who Can Participate

Inclusion Criteria

Are at least 18-years old;
Have suboptimal LV EBD, defined as ≥2 adjacent segments in any apical view that cannot be visualized, at pre-contrast echocardiogram;
Provide their written informed consent and are willing to comply with protocol requirements.

Exclusion Criteria

Patient has severe congestive heart failure (class IV according to the classification of the New York Heart Association);
Patient has uncontrolled angina (i.e., uncontrolled on medication);
Patient had a recent myocardial infarction (within the last 3 days and not stabilized);
Patient has severe arrhythmia, that in the opinion of the Investigator, would interfere with the study conduct;
Patient has severe pulmonary hypertension, that in the opinion of the Investigator, would interfere with the study conduct;
Patient had been treated with any other contrast medium, either intravascular or orally, within 48 hours prior to the first administration;
Has any known allergy to one

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06400004) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

I cannot determine a primary medical condition from the provided information. The data only shows drug names (Lumason/Sulfur Hexafluoride Lipid Type A Microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. Treatment Options in Boston, MA

If you're searching for i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. treatment options in Boston, MA, this clinical trial (NCT06400004) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all i cannot determine a primary medical condition from the provided information. the data only shows drug names (lumason/sulfur hexafluoride lipid type a microspheres) and administration methods, but does not indicate what medical condition this ultrasound contrast agent is being used to diagnose or treat. clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Boston, MA

See all follicular lymphoma clinical trials recruiting in Boston — not just this study.

Browse Follicular Lymphoma Trials in Boston →

Browse More Trials by Condition

Follicular Lymphoma TrialsAtrial Fibrillation TrialsHeart Attack TrialsPulmonary Embolism TrialsAlzheimers Disease TrialsEssential Tremor TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA